Inner Mongolia Furui Medical Science Co., Ltd. (SHE:300049)

China flag China · Delayed Price · Currency is CNY
75.60
-2.50 (-3.20%)
Sep 26, 2025, 3:04 PM CST
98.95%
Market Cap 20.03B
Revenue (ttm) 1.42B
Net Income (ttm) 89.86M
Shares Out 264.98M
EPS (ttm) 0.34
PE Ratio 222.56
Forward PE 104.28
Dividend n/a
Ex-Dividend Date n/a
Volume 11,939,492
Average Volume 17,118,790
Open 77.01
Previous Close 78.10
Day's Range 73.79 - 87.00
52-Week Range 26.61 - 90.68
Beta -0.60
RSI 57.53
Earnings Date Oct 23, 2025

About SHE:300049

Inner Mongolia Furui Medical Science Co., Ltd. engages in the production and sale of pharmaceutical drugs in China and internationally. It operates in two segments, pharmaceutical production and sales; and diagnostic equipment R&D, production and sales. The pharmaceutical production and sales segment produces and sells products, such as Fufang Biejiaruangan tablets and shell fat capsules. The diagnostic equipment R&D, production and sales segment develops, produces, and sells the FibroScan series of liver fibrosis diagnostic instruments. It pro... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1998
Employees 867
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300049
Full Company Profile

Financial Performance

In 2024, SHE:300049's revenue was 1.35 billion, an increase of 16.93% compared to the previous year's 1.15 billion. Earnings were 113.29 million, an increase of 11.54%.

Financial Statements

News

There is no news available yet.